Medtech startup brings Oracle AI to bear on cancer drug research
In recent years, human ingenuity and scientific know-how has developed advanced drugs promising relief and even recovery to millions of...
Read more →In recent years, human ingenuity and scientific know-how has developed advanced drugs promising relief and even recovery to millions of...
Read more →Cyble Research and Intelligence Labs (CRIL) has identified a stealthy Android spyware campaign specifically targeting individuals in South Korea. Active...
Read more →Over half of today’s subpostmasters are experiencing unexplained accounting shortfalls on the controversial Horizon IT system used in branches. Over...
Read more →Ohio is facing a pressing issue of the absence of a statewide standard for cybersecurity. The gap in cybersecurity protocol...
Read more →Chinese APT Earth Baxia target APAC by exploiting GeoServer flaw Pierluigi Paganini September 23, 2024 Suspected China-linked APT Earth Baxia...
Read more →Apple’s latest operating system update, macOS 15, also known as Sequoia, has disrupted the functionality of several prominent security tools....
Read more →Last week on Malwarebytes Labs: Last week on ThreatDown: Stay safe! Our business solutions remove all remnants of ransomware and...
Read more →Sep 23, 2024Ravie LakshmananSoftware Security / Supply Chain Threat actors with ties to North Korea have been observed using poisoned...
Read more →If your local datacentre is running a little hotter than usual this month, that could be because its operators are...
Read more →FreeBSD has disclosed a critical remote code execution (RCE) vulnerability affecting its bhyve hypervisor. This vulnerability, CVE-2024-41721, could allow attackers...
Read more →Passwords are essential for protecting online accounts from compromise, misuse, or deletion. However, remembering and entering them each time you...
Read more →In today’s digital era, data protection and compliance with the General Data Protection Regulation (GDPR) are not just legal requirements;...
Read more →